← FDA Drug Approvals (Drugs@FDA)

RIFAMPIN AND ISONIAZID

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA INTL PHARMS · Approved 2005-07-29

Drug application

FDA Application #

ANDA065221

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIFAMPIN AND ISONIAZID

Generic name

Isoniazid

Active ingredients

ISONIAZID; RIFAMPIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

HIKMA INTL PHARMS

First approval

2005-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown